Yanfeng Xi

机构：Qingdao Agricultural University, Shandong University, Henan University, Shanxi Medical University, Qingdao Binhai University, Gansu University of Traditional Chinese Medicine, Shanxi Provincial Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences · ORCID：0000-0003-0180-8610

发表论文 169 篇 · 总被引 2000 次 · h-index 22

代表论文

• The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11 (2024 · Cancer Gene Therapy · 被引 11)
• Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study (2024 · 癌症：英文版 · 被引 11)
• Transgenic expression of mAChR-C dsRNA in maize confers efficient locust control (2025 · Plant Communications · 被引 9)
• Expression and prognostic significance of CD93 in blood vessels in colorectal cancer: an immunohistochemical analysis of 134 cases (2025 · BMC Gastroenterology · 被引 5)
• Oxidative stress and Kras mutation in Mist1+ cells act in a double-hit manner to drive gastric tumorigenesis (2025 · Cell Reports · 被引 4)
• CNDP1 Overexpression by Promoter Hypomethylation Predicts Poor Prognosis and Immunotherapy Response in Mucosal Melanoma (2025 · Cancer Science · 被引 4)